Newsletter | April 6, 2026

04.06.26 -- The Silent Strategist: AI's "Hidden" Nudges Reshape Pipeline Strategy

FEATURED ARTICLE

The Silent Strategist: AI's "Hidden" Nudges Reshape Pipeline Strategy

With the wrong architecture in place, AI algorithms can 'nudge' biopharmaceutical developers toward unpredicted and misaligned results, according to experts.

INDUSTRY INSIGHTS

Sneak Peek Of Pharma R&D Annual Review

Drug development experts remain intent on pharma’s prospects, especially in China, which have overtaken the US in first-time new drugs and continues to nurture a robust pipeline.

Inside A Family’s 14-Month Path To Gene Therapy Access

See how one family managed to get an investigational gene replacement therapy manufactured and approved by the FDA so their daughter could be dosed just 14 months from her diagnosis.

4 Proven Strategies To Optimize Patient Enrollment, Avoid Rescue Trials

Though rescue studies are common, there are ample tactics to avoid these situations altogether, including robust planning, data analysis, and prioritization of patient recruitment and retention.

Optimizing DSP Development

The biopharmaceutical industry faces mounting downstream processing challenges as it works to purify increasingly complex biologics efficiently, reliably, and at commercial scale.

Bringing Local Payments To International Clinical Trials

Modernize clinical trials by replacing slow international wires with local digital payments. Reduce participant friction and ensure fair, instant reimbursements across the globe.

Set Up And Qualify GMP Laboratories

Discover a GMP microbiology lab was established and qualified in Ireland, providing expertise, staffing, training, and project management to ensure compliant operations and client success.

Scale-Up And Production Of Key Lipids Used In mRNA Delivery Systems

Discover key strategies for overcoming challenges in the industrial-scale production of ionizable and PEG lipids to optimize mRNA vaccine formulation and address critical manufacturing requirements.